About the Speaker
Zameel Cader Is Scientific Director of IMI StemBANCC and is the Director of the Oxford Headache Centre. He is also Clinical Director for Mental Health, Dementia and Neurology for the Strategic Clinical Network. He is Associate Professor in Clinical Neurosciences at the Nuffield Department of Clinical Neuroscience and the Weatherall Institute of Molecular Medicine. His research programme is focused on understanding the disease process in neurodysfunctional disorders such as migraine and neurodegenerative disorders such as Alzheimer's Disease using cell biology, model organism and human imaging studies. His group is now working with MRC Technology to bring more effective treatments arising from these findings to clinic.
AbstractThis presentation will focus on stemBANCC and its progress in developing disease relevant models as well as how we hope to turn these into drug screening assays.
Disease Modelling and Drug Discovery in Neurological Disorders
Video Apr 29, 2016
LC-MS/MS for Bioanalytical Peptide and Protein Quantification: MS ConsiderationsVideo
Caitlin Dunning, Associate Scientist, discusses how to use mass spectrometry to develop sensitive, selective, and robust quantification methods for peptide and protein quantification, including: basic mass spectrometry considerations, MS tuning, and best practices for success.WATCH NOW
How One Scientist Averted a National Health CrisisVideo
In 1960, Frances Kelsey was one of the Food and Drug Administration’s newest recruits. Before the year was out, she would begin a fight that would save thousands of lives — though no one knew it at the time.WATCH NOW
Now you can visualize and analyze complex 3D cell models – with Harmony 4.8 softwareVideo
See what you’re missing with the new capabilities of Harmony® 4.8 software for imaging, analysis, and visualization of complex 3D cell models.WATCH NOW
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018